Geode Capital Management, LLC Bio Path Holdings Inc Transaction History

Geode Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.36 - $0.75 $5,756 - $11,991	15,989 Added 16.93%	110,438 $50,000
Q3 2023 Nov 13, 2023	BUY	$0.36 - $1.78 $9,749 - $48,204	27,081 Added 40.2%	94,449 $34,000
Q4 2022 Feb 13, 2023	SELL	$1.32 - $2.81 $199 - $424	-151 Reduced 0.22%	67,368 $101,000
Q2 2022 Aug 12, 2022	BUY	$2.83 - $4.02 $4,912 - $6,978	1,736 Added 2.64%	67,519 $261,000
Q3 2021 Nov 12, 2021	BUY	$5.13 - $6.78 $2,205 - $2,915	430 Added 0.66%	65,783 $337,000

Q2 2021 Aug 13, 2021	BUY	$5.13 - $7.63 $44,954 - $66,861	8,763 Added 15.49%	65,353 $435,000
Q1 2021 May 12, 2021	BUY	$3.63 - $11.77 $81,315 - $263,659	22,401 Added 65.52%	56,590 $397,000
Q4 2020 Feb 12, 2021	BUY	$3.21 - $5.26 $43,482 - $71,251	13,546 Added 65.62%	34,189 $119,000
Q4 2019 Feb 13, 2020	BUY	$6.97 - $12.3 $4,676 - $8,253	671 Added 3.36%	20,643 $164,000
Q3 2019 Nov 12, 2019	BUY	$9.45 - $17.17 $57,607 - $104,668	6,096 Added 43.93%	19,972 $189,000
Q2 2019 Aug 14, 2019	BUY	$12.52 - $20.81 $173,727 - $288,759	13,876 New	13,876 $185,000
Q1 2019 May 14, 2019	SELL	$1.81 - $38.86 $94,948 - $2.04 Million	-52,458 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$3.2 - $12.8 $167,865 - $671,462	52,458 New	52,458 $9,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $13M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.